Eruzun, H. “Sclerosing Cholangitis Associated With dabrafenib–trametinib Therapy: BRAF/MEK Inhibitors Should Be Considered”. Journal of Gastrointestinal and Liver Diseases, vol. 35, no. 1, Mar. 2026, pp. 136-7, doi:10.15403/jgld-6698.